Nguyen MH,Wong G,Gane E,Kao JH,Dusheiko G .2020 .Hepatitis B Virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev, 33(2) : 19-19.
Hsu YC,Huang DQ,Nguyen MH .2023 .Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol, 20(8) : 524-37.
Revill PA,Chisari FV,Block JM,Dandri M,Gehring AJ,Guo H .2019 .A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol, 1253(19) : 30151-7.
Weyand CM,Goronzy JJ .2021 .The immunology of rheumatoid arthritis. Nat Immunol, 22(1) : 10-8.
Alivernini S,Firestein GS,McInnes IB .2022 .The pathogenesis of rheumatoid arthritis. Immunity, 11(12) : 2255-70.
Scherer HU,Häupl T,Burmester GR .2019 .The etiology of rheumatoid arthritis. J Autoimmun, 110 : 102400.
Croia C,Bursi R,Sutera D,Petrelli F,Alunno A,Puxeddu I. .2019 .One year in review 2019: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol, 37(3) : 347-57.
Ridola L,Zullo A,Laganà B,Lorenzetti R,Migliore A,Pica R .2021 .Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice. Ann dell'Istituto Super Sanita, 57(3) : 08-8.
Kuo MH,Tseng CW,Ko PH,Wang ST,Lu MC,Tung CH .2024 .HBV reactivation in HBsAg−/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs. Liver Int, 44(2) : 497-507.
Butola LK,Anjanker A,Vagga A,Kaple MN .2020 .Endogenous factor and pathophysiology of rheumatoid arthritis: an autoimmune disease from decades. Int J Cur Res Rev, 10(22) : 34-40.
Watanabe T,Fukae J,Fukaya S,Sawamukai N,Isobe M,Matsuhashi M .2019 .Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying anti rheumatic drugs. Int J Rheum Dis, 22(4) : 13401-185X.
Mehmood S,Raza H,Abid F,Saeed N,Rehman HM,Javed S .2020 .National prevalence rate of hepatitis B and C in Pakistan and its risk factors. J Public Health, 28 : 751-64.
Khan A,Ahmad I,Health J Public .2023 .Intra-familial spread of HBV among HbsAg positive parents and their children in a defined rural community of district Peshawar, Pakistan. , 13(1) : 11-4.
Hsu CS,Lang HC,Huang KY,Lin HH,Chen CL .2016 .Association of rheumatoid arthritis and hepatitis B infection: a nationwide nested case-control study from 1999 to 2009 in Taiwan. Medicine (Baltimore), 95(18) : .
Watanabe R,Ishii T,Kobayashi H,Asahina I,Takemori H,Izumiyama T .2014 .Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey. Tohoku J Exp Med, 233 : 129-33.
Shi Y,Zheng M. Hepatitis .2020 .B virus persistence and reactivation. BMJ, 370 : .
Tien YC,Yen HH,Chiu YM .2017 .Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAbpositive patients receiving rituximab for rheumatoid arthritis. Clin Exp Rheumatol, 35 : 831-6.
Alishiri GH,Ghorbani GA,Ahmad S. .2013 .Prevalence of hepatitis B infection in rheumatoid arthritis patients. Pakistan J Biol Sci, 747 : 747-50.
Yılmaz N,Karadağ Ö,Kimyon G,Yazıcı A,Yılmaz S,Kalyoncu U .2014 .Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: a multi center countrywide study. Eur J Rheumatol, 1(2) : 51-4.
Golkocheva-Markova E,Ivanova S,Ivanova M,Gekova I,Stoilov N,Kostadinova A .2015 .Prevalence of the hepatitis B virus markers among patients with ankylosing spondylitis and rheumatoid arthritis. J BioSci Biotechnol, : .
Duan L,Yang C,Cai T,Li W. .2023 .Clinical effects of HBV infection on patients with rheumatoid arthritis and systemic lupus Erythematosus. Pak J Med Sci, 39(5) : 7232-50.
Lan TY,Lin YC,Tseng TC,Yang HC,Kao JH,Cheng CF .2023 .Risk of Hepatitis B Virus (HBV) reactivation in HBsAg-negative, antiHBc-negative patients receiving rituximab for autoimmune diseases in HBV endemic areas. Gut Liver, 17(2) : 288.